Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis

Abstract Views: 1107
PDF: 948
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Systemic sclerosis (SSc) is a dysimmune disorder of connective tissue characterized by disregulation of endothelial function and progressive tissue fibrosis. Although many studies have been carried out the pathogenesis of SSc is an issue still elusive. In a pioneer paper Murrel DF suggested oxidative stress (OS) as the keystone linking altered immune tolerance, endothelial injury and pro-fibrotic phenotype of SSc (1). In the last decade, this intriguing hypothesis has been strengthened by several firm evidences obtained at a cellular and molecular level. OS refers to a condition characterized by an imbalance in prooxidants and antioxidants, which results in damage to macromolecules...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Erre, G., & Passiu, G. (2009). Antioxidant effect of Iloprost: current knowledge and therapeutic implications for systemic sclerosis. Reumatismo, 61(2), 90–97. https://doi.org/10.4081/reumatismo.2009.90